Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has conducted a Remote ...

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA) at Zydus' formulations manufacturing facility at Matoda in Gujarat for the Prior Approval Supplement (PAS) of ...

Sun Pharmaceutical Industries has announced the launch of FEXUCLUE, a novel potassium-competitive acid blocker (P-CAB), in India. The drug, available in 40 mg tablets, is approved as a new treatment ...

Atorvastatin is a prescription drug used for lowering cholesterol and triglyceride levels and reducing certain heart-related risks. Find out about possible interactions with alcohol, other drugs ...

These 13 formulations include atorvastatin 40 mg tablet, atorvastatin 80 mg tablet, carbamazepine 200 mg tablet, levetiracetam 500 mg tablet, levetiracetam 750 mg tablet, linezolid 600 mg tablet, ...

Background In Europe, the urate-lowering drug febuxostat for gout is registered in two strenghts, 80 mg and 120 mg, but not 40 mg. Starting 40 mg can sometimes be considered desirable, for instance ...

Also, in the STOP-CA study, atorvastatin was administered only at a dosage of 40 mg/day. Therefore, it was not possible to assess any potential effects with other doses or treatment durations.

The fixed-dose combination tablet LCP-AtorFen 40/100 mg resulted in a greater improvement in primary lipid parameters compared to either 40 mg atorvastatin or the higher dose 145 mg fenofibrate ...

Participants will be randomly assigned to oral atorvastatin (40 mg daily) or matching placebo (1:1 ratio). The co-primary endpoints are disability-free survival defined as survival-free of dementia ...